Sunday, January 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

CDC RFI: Collection of Specimens During Outbreak or Public Health Emergency

by Global Biodefense Staff
June 17, 2019
Vials of biological samples taken during an outbreak by public health professional

Credit: Shutterstock

Infectious disease outbreaks, even small or remote ones, may be global threats and require a swift public health response. Accurate, accessible, and robust diagnostic tests are critical for patient management and public health response. However, when a new threat emerges, such as the Zika virus, diagnostic tests may not exist and have to be rapidly developed and implemented by public health and clinical laboratories to support response efforts.

During emergencies, access to samples and reference materials needed for test development, performance evaluation, and deployment is a challenge for CDC programs, public health partners, and private diagnostics manufacturers. A recent GAO report (GAO-17-445) showed that manufacturers of diagnostic assays experienced difficulty obtaining Zika positive clinical specimens, hindering the development of new Zika diagnostics.

To address the need for rapid access to outbreak-related samples, the CDC is interested in developing the capability to rapidly document informed consent and collect specimens from affected patients during outbreaks of infectious disease or public health emergencies.

CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency, obtain informed consent, collect specimens (blood, urine, swabs, etc.) from identified patients, and safely ship these specimens to CDC in accordance with all applicable local, state, and federal and/or international laws, and regulations.

Additionally, the agency is seeking to obtain information, needs, capabilities, constraints, capacities, and requirements of those vendors and companies who do have an interest (or potential interest) in providing the needed services.

Further information is available via Solicitation Number: 75D301-19-Q-70417.

Tags: RFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers
Preparedness

Predictive Intelligence for Pandemic Prevention Grant Awarded to Virginia Tech Researchers

October 25, 2022
dressed head to toe in protective suit and gloves, a worker places a dropper of liquid onto a small plastic device to test for Ebola virus
Outbreak News

How Prepared is Uganda for the Current Ebola Outbreak?

September 24, 2022
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC